SOM0226

· SOM Innovation Biotech SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SOM0226, covering 2016-11-30 to 2016-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of SOM0226 in Familial Amyloid Polyneuropathy [Phase 1, Phase 2]